Influence of caloric restriction on constitutive expression of NF-κb in an experimental mouse astrocytoma

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Mulrooney, Tiernan J ^a   Marsh, Jeremy ^b   Urits, Ivan ^c   Seyfried, Thomas N ^c   Mukherjee, Purna ^c  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c BOSTON COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 2; TRANSCRIPTION FACTOR RELA; 3 HYDROXYBUTYRIC ACID; ACTIN BINDING PROTEIN; AIF1 PROTEIN, MOUSE; AUTACOID; CALCIUM BINDING PROTEIN; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; DNA; I KAPPA B; LEUKOCYTE ANTIGEN; PTGS2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; BRAIN TISSUE; CALORIC RESTRICTION; CANCER CELL; CANCER INHIBITION; CANCER SURVIVAL; CONTROLLED STUDY; ENCEPHALITIS; ENZYME ACTIVITY; INFLAMMATORY CELL; MALE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THERAPY EFFECT; TRANSACTIVATION; TRANSCRIPTION REGULATION; ANIMAL; BLOOD; BODY WEIGHT; BRAIN; C57BL MOUSE; CELL NUCLEUS; CELL PROLIFERATION; CYTOSOL; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROMOTER REGION; PROTEIN BINDING; WESTERN BLOTTING;

3-HYDROXYBUTYRIC ACID; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ASTROCYTOMA; BLOOD GLUCOSE; BLOTTING, WESTERN; BODY WEIGHT; BRAIN; CALCIUM-BINDING PROTEINS; CALORIC RESTRICTION; CELL NUCLEUS; CELL PROLIFERATION; CYCLOOXYGENASE 2; CYTOSOL; DNA, NEOPLASM; I-KAPPA B PROTEINS; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; MICROFILAMENT PROTEINS; NF-KAPPA B; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING;

EID: 79953315614     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018085     Document Type: Article

References (104)

1. Fisher PG, Buffler PA, (2005) Malignant gliomas in 2005: where to GO from here? Jama 293: 615-617.
2. Nicholson HS, Kretschmar CS, Krailo M, Bernstein M, Kadota R, et al. (2007) Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group. Cancer 110: 1542-1550.
3. Lowry JK, Snyder JJ, Lowry PW, (1998) Brain tumors in the elderly: recent trends in a Minnesota cohort study. Arch Neurol 55: 922-928.
4. Jukich PJ, McCarthy BJ, Surawicz TS, Freels S, Davis FG, (2001) Trends in incidence of primary brain tumors in the United States, 1985-1994. Neuro Oncol 3: 141-151.
5. Smith JS, Jenkins RB, (2000) Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications. Front Biosci 5: D213-231.
6. Ohgaki H DP, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, et al. (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64: 6892-6899.
7. Lu S, Ahn D, Johnson G, Law M, Zagzag D, et al. (2004) Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration index. Radiology 232: 221-228.
8. Ludwig HC, Feiz-Erfan I, Bockermann V, Behnke-Mursch J, Schallock K, et al. (2000) Expression of nitric oxide synthase isozymes (NOS I-III) by immunohistochemistry and DNA in situ hybridization. Correlation with macrophage presence, vascular endothelial growth factor (VEGF) and oedema volumetric data in 220 glioblastomas. Anticancer Res 20: 299-304.
9. Badie B, Schartner JM, Hagar AR, Prabakaran S, Peebles TR, et al. (2003) Microglia cyclooxygenase-2 activity in experimental gliomas: possible role in cerebral edema formation. Clin Cancer Res 9: 872-877.
10. Albini A, Sporn MB, (2007) The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7: 139-147.
11. Mantovani A, Schioppa T, Porta C, Allavena P, Sica A, (2006) Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 25: 315-322.
12. Carlson MR, Pope WB, Horvath S, Braunstein JG, Nghiemphu P, et al. (2007) Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2. Clin Cancer Res 13: 2592-2598.
13. Pope WB, Sayre J, Perlina A, Villablanca JP, Mischel PS, et al. (2005) MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol 26: 2466-2474.
14. Gustafson MP, Lin Y, New KC, Bulur PA, O'Neill BP, et al. Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone. Neuro Oncol.
15. Derr RL, Ye X, Islas MU, Desideri S, Saudek CD, et al. (2009) Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma. J Clin Oncol 27: 1082-1086.
16. Lukins MB, Manninen PH, (2005) Hyperglycemia in patients administered dexamethasone for craniotomy. Anesth Analg 100: 1129-1133.
17. Rutz HP, Herr I, (2005) Glucocorticoid administration in antiemetic therapy: Is it safe? Cancer 103: 2656; author reply 2656-2657.
18. Rutz HP, Hofer S, Peghini PE, Gutteck-Amsler U, Rentsch K, et al. (2005) Avoiding glucocorticoid administration in a neurooncological case. Cancer Biol Ther 4: 1186-1189.
19. Mukherjee P, Abate LE, Seyfried TN, (2004) Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors. Clin Cancer Res 10: 5622-5629.
20. Mukherjee P, El-Abbadi MM, Kasperzyk JL, Ranes MK, Seyfried TN, (2002) Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. Br J Cancer 86: 1615-1621.
21. Mukherjee P, Mulrooney TJ, Marsh J, Blair D, Chiles TC, et al. (2008) Differential effects of energy stress on AMPK phosphorylation and apoptosis in experimental brain tumor and normal brain. Mol Cancer 7: 37.
22. Marsh J, Mukherjee P, Seyfried TN, (2008) Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma. Clin Cancer Res 14: 7751-7762.
23. Zhou W, Mukherjee P, Kiebish MA, Markis WT, Mantis JG, et al. (2007) The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr Metab (Lond) 4: 5.
24. Tsunoda K, Kitange G, Anda T, Shabani HK, Kaminogo M, et al. (2005) Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion. Brain Tumor Pathol 22: 79-87.
25. Wang H, Cho CH., Effect of NF-κB Signaling on Apoptosis in Chronic Inflammation-Associated Carcinogenesis. Curr Cancer Drug Targets.
26. Atkinson GP, Nozell SE, Harrison DK, Stonecypher MS, Chen D, et al. (2009) The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma. Oncogene 28: 3735-3745.
27. Xie TX, Xia Z, Zhang N, Gong W, Huang S., Constitutive NF-kappaB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma. Oncol Rep 23: 725-732.
28. Angileri FF, Aguennouz M, Conti A, La Torre D, Cardali S, et al. (2008) Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas. Cancer 112: 2258-2266.
29. Mancino A, Lawrence T. Nuclear factor-kappaB and tumor-associated macrophages. Clin Cancer Res 16: 784-789.
30. Staudt LM., Oncogenic Activation of NF-{kappa}B. Cold Spring Harb Perspect Biol 2: a000109.
31. Li J, Gong LY, Song LB, Jiang LL, Liu LP, et al. Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway. Am J Pathol 176: 699-709.
32. Karin M, Lin A, (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221-227.
33. Nabel GJ, Verma IM, (1993) Proposed NF-kappa B/I kappa B family nomenclature. Genes Dev 7: 2063.
34. Korkolopoulou P, Levidou G, Saetta AA, El-Habr E, Eftichiadis C, et al. (2008) Expression of nuclear factor-kappaB in human astrocytomas: relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival. Hum Pathol 39: 1143-1152.
35. Karin M, Ben-Neriah Y, (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18: 621-663.
36. Baeuerle PA, Baltimore D, (1988) I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242: 540-546.
37. Karin M, (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436.
38. Portnow J, Suleman S, Grossman SA, Eller S, Carson K, (2002) A cyclooxygenase-2 (COX-2) inhibitor compared with dexamethasone in a survival study of rats with intracerebral 9L gliosarcomas. Neuro Oncol 4: 22-25.
39. Csiszar A, Labinskyy N, Jimenez R, Pinto JT, Ballabh P, et al. (2009) Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: role of circulating factors and SIRT1. Mech Ageing Dev 130: 518-527.
40. Mitchell JR, Verweij M, Brand K, van de Ven M, Goemaere N, et al. Short-term dietary restriction and fasting precondition against ischemia reperfusion injury in mice. Aging Cell 9: 40-53.
41. McMillan DC, Sattar N, McArdle CS, (2006) ABC of obesity. Obesity and cancer. Bmj 333: 1109-1111.
42. Hursting SD, Nunez NP, Varticovski L, Vinson C, (2007) The obesity-cancer link: lessons learned from a fatless mouse. Cancer Res 67: 2391-2393.
43. Calle EE, Kaaks R, (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4: 579-591.
44. Jenks S Researchers explore mechanisms that may link obesity and cancer. J Natl Cancer Inst 102: 519-521.
45. Dixit VD, (2008) Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span. J Leukoc Biol 84: 882-892.
46. Fenton JI, Nunez NP, Yakar S, Perkins SN, Hord NG, et al. (2009) Diet-induced adiposity alters the serum profile of inflammation in C57BL/6N mice as measured by antibody array. Diabetes Obes Metab 11: 343-354.
47. Hursting SD, Smith SM, Lashinger LM, Harvey AE, Perkins SN., Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. Carcinogenesis 31: 83-89.
48. Johnson JB, Summer W, Cutler RG, Martin B, Hyun DH, et al. (2007) Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med 42: 665-674.
49. Clement K, Viguerie N, Poitou C, Carette C, Pelloux V, et al. (2004) Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. Faseb J 18: 1657-1669.
50. Seyfried TN, (2001) Perspectives on brain tumor formation involving macrophages, glia, and neural stem cells. Perspect Biol Med 44: 263-282.
51. Dong W, Selgrade MK, Gilmour IM, Lange RW, Park P, et al. (1998) Altered alveolar macrophage function in calorie-restricted rats. Am J Respir Cell Mol Biol 19: 462-469.
52. Harvey AlisonE., GO, Nunez NomeliP., Perkins SusanN., Hursting StephenD., (2010) The anticancer effects of calorie restriction on MC38 colon tumors are associated with decreased macrophage infiltration Cancer Prevention Research 3 (Meeting Abstract Supplement), B54, January 7.
53. Flavin HJ, Wieraszko A, Seyfried TN, (1991) Enhanced aspartate release from hippocampal slices of epileptic (El) mice. J Neurochem 56: 1007-1011.
54. Seyfried TN, El-Abbadi M, Roy ML, (1992) Ganglioside distribution in murine neural tumors. Mol Chem Neuropathol 17: 147-167.
55. Martinez-Murillo R, Martinez A, (2007) Standardization of an orthotopic mouse brain tumor model following transplantation of CT-2A astrocytoma cells. Histol Histopathol 22: 1309-1326.
56. Ranes MK, El-Abbadi M, Manfredi MG, Mukherjee P, Platt FM, et al. (2001) N-butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours. Br J Cancer 84: 1107-1114.
57. Williamson DH, Mellanby J, Krebs HA, (1962) Enzymic determination of D(-)-beta-hydroxybutyric acid and acetoacetic acid in blood. Biochem J 82: 90-96.
58. Krebs HA, Williamson DH, Bates MW, Page MA, Hawkins RA, (1971) The role of ketone bodies in caloric homeostasis. Adv Enzyme Reg 9: 387-409.
59. Hayashi S, Yamamoto M, Ueno Y, Ikeda K, Ohshima K, et al. (2001) Expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1, and c-Myc in human astrocytomas. Neurol Med Chir (Tokyo) 41: 187-195.
60. Seyfried TN, Sanderson TM, El-Abbadi MM, McGowan R, Mukherjee P, (2003) Role of glucose and ketone bodies in the metabolic control of experimental brain cancer. Br J Cancer 89: 1375-1382.
61. Shono T, Tofilon PJ, Bruner JM, Owolabi O, Lang FF, (2001) Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Cancer Res 61: 4375-4381.
62. Autieri MV, (1996) cDNA cloning of human allograft inflammatory factor-1: tissue distribution, cytokine induction, and mRNA expression in injured rat carotid arteries. Biochem Biophys Res Commun 228: 29-37.
63. Ohsawa K, Imai Y, Sasaki Y, Kohsaka S, (2004) Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity. J Neurochem 88: 844-856.
64. Kimura M, Kawahito Y, Obayashi H, Ohta M, Hara H, et al. (2007) A critical role for allograft inflammatory factor-1 in the pathogenesis of rheumatoid arthritis. J Immunol 178: 3316-3322.
65. Utans U, Arceci RJ, Yamashita Y, Russell ME, (1995) Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection. J Clin Invest 95: 2954-2962.
66. Pashenkov M, Efendic S, Zhu J, Zou LP, Ostenson CG, et al. (2000) Augmented expression of daintain/allograft inflammatory factor-1 is associated with clinical disease: dynamics of daintain/allograft inflammatory factor-1 expression in spleen, peripheral nerves and sera during experimental autoimmune neuritis. Scand J Immunol 52: 117-122.
67. Yang ZF, Ho DW, Lau CK, Lam CT, Lum CT, et al. (2005) Allograft inflammatory factor-1 (AIF-1) is crucial for the survival and pro-inflammatory activity of macrophages. Int Immunol 17: 1391-1397.
68. Matzer SP, Rodel F, Strieter RM, Rollinghoff M, Beuscher HU, (2004) Constitutive expression of CXCL2/MIP-2 is restricted to a Gr-1high, CD11b+, CD62Lhigh subset of bone marrow derived granulocytes. Int Immunol 16: 1675-1683.
69. Wolpe SD, Sherry B, Juers D, Davatelis G, Yurt RW, et al. (1989) Identification and characterization of macrophage inflammatory protein 2. Proc Natl Acad Sci U S A 86: 612-616.
70. Huang S, Paulauskis JD, Godleski JJ, Kobzik L, (1992) Expression of macrophage inflammatory protein-2 and KC mRNA in pulmonary inflammation. Am J Pathol 141: 981-988.
71. Mancardi S, Vecile E, Dusetti N, Calvo E, Stanta G, et al. (2003) Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells. Immunology 108: 523-530.
72. Armstrong DA, Major JA, Chudyk A, Hamilton TA, (2004) Neutrophil chemoattractant genes KC and MIP-2 are expressed in different cell populations at sites of surgical injury. J Leukoc Biol 75: 641-648.
73. Zampetaki A, Mitsialis SA, Pfeilschifter J, Kourembanas S, (2004) Hypoxia induces macrophage inflammatory protein-2 (MIP-2) gene expression in murine macrophages via NF-kappaB: the prominent role of p42/p44 and PI3 kinase pathways. Faseb J 18: 1090-1092.
74. Ikeda S, Saito H, Fukatsu K, Inoue T, Han I, et al. (2001) Dietary restriction impairs neutrophil exudation by reducing CD11b/CD18 expression and chemokine production. Arch Surg 136: 297-304.
75. Holness CL, Simmons DL, (1993) Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 81: 1607-1613.
76. Nozell S, Laver T, Moseley D, Nowoslawski L, De Vos M, et al. (2008) The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes. Mol Cell Biol 28: 6632-6645.
77. Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD, (1997) The codependence of angiogenesis and chronic inflammation. Faseb J 11: 457-465.
78. Kobayashi H, Lin PC, (2009) Angiogenesis links chronic inflammation with cancer. Methods Mol Biol 511: 185-191.
79. Fiedler U, Augustin HG, (2006) Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol 27: 552-558.
80. Lewis CE, Pollard JW, (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66: 605-612.
81. Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, et al. (1999) Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med 5: 828-831.
82. Li Q, Verma IM, (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734.
83. Hagemann T, Robinson SC, Schulz M, Trumper L, Balkwill FR, et al. (2004) Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 25: 1543-1549.
84. Wang H, Wang H, Zhang W, Huang HJ, Liao WS, et al. (2004) Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas. Lab Invest 84: 941-951.
85. Seyfried TN, Mukherjee P, (2005) Targeting energy metabolism in brain cancer: review and hypothesis. Nutr Metab (Lond) 2: 30.
86. Maalouf M, Rho JM, Mattson MP, (2009) The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev 59: 293-315.
87. Heilbronn LK, Ravussin E, (2003) Calorie restriction and aging: review of the literature and implications for studies in humans. Am J Clin Nutr 78: 361-369.
88. Ruskin DN, Kawamura M, Masino SA, (2009) Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet. PLoS One 4: e8349.
89. Zuccoli G, Marcello N, Pisanello A, Servadei F, Vaccaro S, et al. Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report. Nutr Metab (Lond) 7: 33.
90. Veech RL, (2004) The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 70: 309-319.
91. Annabi B, Laflamme C, Sina A, Lachambre MP, Beliveau R, (2009) A MT1-MMP/NF-kappaB signaling axis as a checkpoint controller of COX-2 expression in CD133+ U87 glioblastoma cells. J Neuroinflammation 6: 8.
92. Temel SG, Kahveci Z, (2009) Cyclooxygenase-2 expression in astrocytes and microglia in human oligodendroglioma and astrocytoma. J Mol Histol 40: 369-377.
93. Chung HY, Kim HJ, Kim JW, Yu BP, (2001) The inflammation hypothesis of aging: molecular modulation by calorie restriction. Ann N Y Acad Sci 928: 327-335.
94. Chung HY, Sung B, Jung KJ, Zou Y, Yu BP, (2006) The molecular inflammatory process in aging. Antioxid Redox Signal 8: 572-581.
95. Jung KJ, Lee EK, Kim JY, Zou Y, Sung B, et al. (2009) Effect of short term calorie restriction on pro-inflammatory NF-kB and AP-1 in aged rat kidney. Inflamm Res 58: 143-150.
96. Liu S, Tan WY, Chen QR, Chen XP, Fu K, et al. (2008) Daintain/AIF-1 promotes breast cancer proliferation via activation of the NF-kappaB/cyclin D1 pathway and facilitates tumor growth. Cancer Sci 99: 952-957.
97. Huysentruyt LC, Mukherjee P, Banerjee D, Shelton LM, Seyfried TN, (2008) Metastatic cancer cells with macrophage properties: evidence from a new murine tumor model. Int J Cancer 123: 73-84.
98. Shelton LM, Mukherjee P, Huysentruyt LC, Urits I, Rosenberg JA, et al. A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion. J Neurooncol.
99. Jia J, Cai Y, Wang R, Fu K, Zhao YF, (2010) Overexpression of allograft inflammatory factor-1 promotes the proliferation and migration of human endothelial cells (HUV-EC-C) probably by up-regulation of basic fibroblast growth factor. Pediatr Res 67: 29-34.
100. Kim DS, Han JH, Kwon HJ, (2003) NF-kappaB and c-Jun-dependent regulation of macrophage inflammatory protein-2 gene expression in response to lipopolysaccharide in RAW 264.7 cells. Mol Immunol 40: 633-643.
101. Seyfried TN, Shelton LM., Cancer as a metabolic disease. Nutr Metab (Lond) 7: 7.
102. Seyfried TN, Kiebish MA, Marsh J, Shelton LM, Huysentruyt LC, et al. Metabolic management of brain cancer. Biochim Biophys Acta.
103. Shelton LM, Huysentruyt LC, Mukherjee P, Seyfried TN., (0038) Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse ASN Neuro 2: e00038.
104. Mukherjee P, Sotnikov AV, Mangian HJ, Zhou JR, Visek WJ, et al. (1999) Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. J Natl Cancer Inst 91: 512-523.